|
|
|
|
Stroke Epidemiology - Researchers from Yale University report details of new studies and findings in the area
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Stroke Epidemiology Researchers from Yale University report details...
|
|
|
Dabigatran etexilate shows greater reductions than warfarin in stroke in patients with atrial fibrillation acr
- Compared to well-controlled warfarin, dabigatran etexilate provided consistent benefits in stroke prevention in atrial fibrillation (AF), irrespective of a patient's risk profile for stroke(1) - Dabigatran etexilate 150mg bid reduced the number of ...
|
|
|
Blood pressure changes before stroke
"Swings in blood pressure 'could better predict stroke than average high readings'" reported The Daily Telegraph.The paper reported that "variations in people's blood pressure rather than the average level predicts stroke most powerfully". The...
|
|
|
More Evidence That Swings in Blood Pressure Raise Stroke Risk
SUNDAY, March 14 (HealthDay News) --Following on recent, similar research, a large five-year study points to fluctuations in blood pressure over time as a key indicator of stroke risk.In the study, British researchers tracked the health of more than 19...
|
|
|
Patients Recently Suffering Non-Severe Strokes May Be Eligible For Clinical Trial Of Minimally Invasive Stenti
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally...
|
|
|
More Evidence That Swings in Blood Pressure Raise Stroke Risk
SUNDAY, March 14 (HealthDay News) --Following on recent, similar research, a large five-year study points to fluctuations in blood pressure over time as a key indicator of stroke risk.In the study, British researchers tracked the health of more than 19...
|
|
|
More Evidence That Swings in Blood Pressure Raise Stroke Risk
SUNDAY, March 14 (HealthDay News) --Following on recent, similar research, a large five-year study points to fluctuations in blood pressure over time as a key indicator of stroke risk.In the study, British researchers tracked the health of more than 19...
|
|
|
Stemedica Files IND Application With FDA For Treatment Of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial...
|
|
|
Desmoteplase enters clinical phase II in Japan in ischaemic stroke representing Lundbeck's first clinical prog
Lundbeck A/S (Lundbeck) today announced the initiation of the first Japanese clinical phase II trial with desmoteplase (DIAS-J) in the treatment of acute ischaemic stroke.This study is required for the approval of the substance for the Japanese market....
|
|
|
Telemedicine Evaluates Stroke In Rural Areas
Medical centers having access to stroke specialists are transmitting their expertise to rural communities via audio/video telemedicine consultation, with clinical results, according to a study.The study, Pooled Analysis of the STRokE DOC and ...
|
|
|
TopAbstracts in Stroke 03/18/2010
TopAbstracts in Stroke are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer-reviewed journals are covered...
|
|
|
Medical News: 2010 Canadian Stroke Congress
Co-hosted by the Heart and Stroke Foundation of Canada, the Canadian Stroke Network, and the Canadian Stroke Consortium, the Canadian Stroke Congress brings together leading stroke experts to exchange ideas and present the latest...
|
|
|
2010 Canadian Stroke Congress
Co-hosted by the Heart and Stroke Foundation of Canada, the Canadian Stroke Network, and the Canadian Stroke Consortium, the Canadian Stroke Congress brings together leading stroke experts to exchange ideas and present the latest...
|
|
|
Portland, OR-Adventist Earns Gold Achievement Award for Stroke Care
Adventist Medical Cente r (AMC) recently received the American Heart Association/American Stroke Association's (AHA/ASA) Get With The Guidelines (GWTG) Stroke Gold Performance Achievement Award.Portland, OR-Adventist Earns Gold Achievement Award...
|
|
|
ReNeuron signs two further manufacturing contracts for ReN001 stem cells
ReNeuron Group (AIM: RENE) has signed two further clinical grade stem cell manufacturing contracts with Angel Biotechnology Holdings (AIM: ABH) in support of ReNeuron's recently approved first-in-man clinical trial with its ReN001 therapy for stroke...
|
|
|
Stemedica Files IND Application with FDA for Treatment of Stroke with Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S.Food and Drug Administration (FDA) for a clinical trial. The trial will assess...
|
|
|
Stemedica Files IND Application with FDA for Treatment of Stroke with Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S.Food and Drug Administration (FDA) for a clinical trial. The trial will assess...
|
|
|
Patients Recently Suffering Non-Severe Strokes May be Eligible for Clinical Trial of Minimally Invasive Stenting Procedure to Open Brain Arteries
Source: Cedars-Sinai Medical Center Newswise Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a...
|
|
|
Taking blood pressure pills cuts risk of dying
Digg Facebook StumbleUpon Delicious E-Mail to a Friend NEW YORK (Reuters Health) - People with high blood pressure who want to reduce their risk of having a stroke or dying prematurely should get their prescriptions filled and see their doctor regularly....
|
|
|
Stemedica Cell Technologies, Inc. Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic
SAN DIEGO, March 19 /PRNewswire/ -- (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S.Food and Drug Administration (FDA) for a clinical trial. The trial...
|
|
|
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
SAN DIEGO, March 19 /PRNewswire/ -- Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration ...
|
|
|
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial...
|
|
|
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial...
|
|
|
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial...
|
|
|
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Stemedica Cell Technologies, Inc.(Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial...
|
